California’s new laws target workers’ biggest fear of AI taking their jobs The state, which is home to many AI companies, is one of the first to roll out workplace regulations targeting the technology The Guardian - US · Oct 3
Tensions high as Medicare drug negotiations advance - Roll Call A law allowing Medicare to negotiate the price of some high-cost drugs remains uncertain, with at least nine lawsuits challenging it. Roll Call · Oct 5, 2023
A more aggressive FTC is starting to target drug mergers and industry middlemen Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and industry middlemen as part of the Biden administration’s push for lower drug prices at the pharmacy counter. Tribune News Service · May 24, 2023
Michael Hiltzik: Eli Lilly is slashing insulin prices, but hold your applause Eli Lilly & Co. played the altruism card like a champ on Mar. 1, when it announced steep price cuts on its insulin products of as much as 70%. Los Angeles Times · Mar 17, 2023
FDA has new leverage over companies looking for a quicker drug approval The Food and Drug Administration has new tools to hold drug companies accountable for promises they make about medications. But the agency has yet to show its hand in using this new power. WEKU · Mar 3, 2023
AbbVie's blockbuster drug Humira finally loses its 20-year, $200 billion monopoly U.S. doctors can now choose Amjevita instead, the first of several close copies of the popular rheumatoid arthritis drug expected this year. But industry-watchers warn consumer savings may be limited. WEKU · Jan 31, 2023